 |
Indian drugmaker Biocon eyes $1bn revenue in 4 yearsIndia's biggest biotech firm Biocon expects revenue to double to $1 billion in four years as it expands in Europe and the US with new products, its chairperson and managing director said on Saturday. In a tie-up with US generi More… |
 |
Final trial confirms Sanofi's dengue vaccine successFrench drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 per cent in a large final clinical trial. Sanofi has invested more than 1.3 billion euros ($1.7 billion) in More… |
 |
Sanofi strong in emerging markets as rivals flagFrench drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed strongly in Chi More… |
 |
Novartis announces massive US jobs cutsNovartis AG is slashing nearly 2,000 jobs in the US ahead of the patent loss of its top-selling blood pressure drug Diovan, the Swiss drugmaker said on Friday, just months after it said would scale back operations in Switzerland. The group More… |
